These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27552000)

  • 1. The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study.
    Campanati A; Molinelli E; Ganzetti G; Giuliodori K; Minetti I; Taus M; Catani M; Martina E; Conocchiari L; Offidani A
    J Dermatolog Treat; 2017 May; 28(3):206-212. PubMed ID: 27552000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment.
    Renzo LD; Saraceno R; Schipani C; Rizzo M; Bianchi A; Noce A; Esposito M; Tiberti S; Chimenti S; DE Lorenzo A
    Dermatol Ther; 2011; 24(4):446-51. PubMed ID: 21910803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment.
    Hmamouchi I; Roux C; Paternotte S; Kolta S; Dougados M; Briot K
    J Rheumatol; 2014 Jun; 41(6):1112-7. PubMed ID: 24737911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.
    Al-Mutairi N; Nour T
    Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis.
    Campanati A; Ganzetti G; Giuliodori K; Marra M; Bonfigli A; Testa R; Offidani A
    Int J Dermatol; 2015 Jul; 54(7):839-45. PubMed ID: 25877149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity.
    Cunha GM; Guzman G; Correa De Mello LL; Trein B; Spina L; Bussade I; Marques Prata J; Sajoux I; Countinho W
    Front Endocrinol (Lausanne); 2020; 11():607. PubMed ID: 33042004
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of decrease in carbohydrate intake with reduction in abdominal fat during 3-month moderate low-carbohydrate diet among non-obese Japanese patients with type 2 diabetes.
    Sasakabe T; Haimoto H; Umegaki H; Wakai K
    Metabolism; 2015 May; 64(5):618-25. PubMed ID: 25682064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater weight loss and hormonal changes after 6 months diet with carbohydrates eaten mostly at dinner.
    Sofer S; Eliraz A; Kaplan S; Voet H; Fink G; Kima T; Madar Z
    Obesity (Silver Spring); 2011 Oct; 19(10):2006-14. PubMed ID: 21475137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate replacement of carbohydrates by dietary fats affects features of metabolic syndrome: a randomized crossover clinical trial.
    Rajaie S; Azadbakht L; Khazaei M; Sherbafchi M; Esmaillzadeh A
    Nutrition; 2014 Jan; 30(1):61-8. PubMed ID: 24290600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
    Desbriere R; Vuaroqueaux V; Achard V; Boullu-Ciocca S; Labuhn M; Dutour A; Grino M
    Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRP, but not TNF-α or IL-6, decreases after weight loss in patients with morbid obesity exposed to intensive weight reduction and balneological treatment.
    Rość D; Adamczyk P; Boinska J; Szafkowski R; Ponikowska I; Stankowska K; Góralczyk B; Ruszkowska-Ciastek B
    J Zhejiang Univ Sci B; 2015 May; 16(5):404-11. PubMed ID: 25990058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of abdominal bioelectrical impedance analysis and comparison with other known parameters in predicting the metabolic syndrome.
    Mousa U; Kut A; Bozkus Y; Cicek Demir C; Anil C; Bascil Tutuncu N
    Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):391-6. PubMed ID: 23696479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
    Gisondi P; Cotena C; Tessari G; Girolomoni G
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Metabolic Syndrome Among Patients with Psoriasis Treated with TNF Inhibitors and the Effects of Anti-TNF Therapy on Their Lipid Profile: A Prospective Cohort Study.
    Botelho KP; Pontes MAA; Rodrigues CEM; Freitas MVC
    Metab Syndr Relat Disord; 2020 Apr; 18(3):154-160. PubMed ID: 31928509
    [No Abstract]   [Full Text] [Related]  

  • 15. Very low-calorie ketogenic diet may allow restoring response to systemic therapy in relapsing plaque psoriasis.
    Castaldo G; Galdo G; Rotondi Aufiero F; Cereda E
    Obes Res Clin Pract; 2016; 10(3):348-52. PubMed ID: 26559897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.
    Walker GE; Verti B; Marzullo P; Savia G; Mencarelli M; Zurleni F; Liuzzi A; Di Blasio AM
    Obesity (Silver Spring); 2007 Aug; 15(8):1933-43. PubMed ID: 17712110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of G308 promoter variant of tumor necrosis factor alpha gene on weight loss and metabolic parameters after a high monounsaturated versus a high polyunsaturated fat hypocaloric diets.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
    Med Clin (Barc); 2013 Sep; 141(5):189-93. PubMed ID: 23601741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis.
    Esposito M; Mazzotta A; Saraceno R; Schipani C; Chimenti S
    Int J Immunopathol Pharmacol; 2009; 22(1):219-25. PubMed ID: 19309569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy-restricted, n-3 polyunsaturated fatty acids-rich diet improves the clinical response to immuno-modulating drugs in obese patients with plaque-type psoriasis: a randomized control clinical trial.
    Guida B; Napoleone A; Trio R; Nastasi A; Balato N; Laccetti R; Cataldi M
    Clin Nutr; 2014 Jun; 33(3):399-405. PubMed ID: 24120032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of carbohydrate versus fat restriction on serum levels of adipocytokines, markers of inflammation, and endothelial function among women with the metabolic syndrome: a randomized cross-over clinical trial.
    Rajaie S; Azadbakht L; Saneei P; Khazaei M; Esmaillzadeh A
    Ann Nutr Metab; 2013; 63(1-2):159-67. PubMed ID: 24021709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.